{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:38:08Z","timestamp":1792784288187,"version":"4.5.0"},"reference-count":96,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Science and Technology Development Fund (FDCT) of Macau SAR","award":["FDCT\/119\/2013\/A3"],"award-info":[{"award-number":["FDCT\/119\/2013\/A3"]}],"id":[{"id":"https:\/\/ror.org\/05vna4324","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Multi-Year Research Grant of the University of Macau","award":["MYRG2015-00181-FHS"],"award-info":[{"award-number":["MYRG2015-00181-FHS"]}],"id":[{"id":"https:\/\/ror.org\/01r4q9n85","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Matching Research Grant of the University of Macau","award":["MRG002\/JSS\/2015\/FHS"],"award-info":[{"award-number":["MRG002\/JSS\/2015\/FHS"]}],"id":[{"id":"https:\/\/ror.org\/01r4q9n85","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12272-015-0628-1","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T22:19:28Z","timestamp":1436307568000},"page":"1617-1626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Existing drugs and their application in drug discovery targeting cancer stem cells"],"prefix":"10.1007","volume":"38","author":[{"given":"Junfang","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joong Sup","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"key":"628_CR1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","volume":"2","author":"LN Abdullah","year":"2013","unstructured":"Abdullah, L.N., and E.K. Chow. 2013. Mechanisms of chemoresistance in cancer stem cells. Clinical and Translational Medicine 2: 3.","journal-title":"Clinical and Translational Medicine"},{"key":"628_CR2","doi-asserted-by":"crossref","first-page":"e91983","DOI":"10.1371\/journal.pone.0091983","volume":"9","author":"EV Abel","year":"2014","unstructured":"Abel, E.V., E.J. Kim, J. Wu, M. Hynes, F. Bednar, E. Proctor, L. Wang, M.L. Dziubinski, and D.M. Simeone. 2014. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer. PLoS One 9: e91983.","journal-title":"PLoS One"},{"key":"628_CR3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/1471-2407-14-317","volume":"14","author":"K Abubaker","year":"2014","unstructured":"Abubaker, K., R.B. Luwor, H. Zhu, O. McNally, M.A. Quinn, C.J. Burns, E.W. Thompson, J.K. Findlay, and N. Ahmed. 2014. Inhibition of the JAK2\/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden. BMC Cancer 14: 317.","journal-title":"BMC Cancer"},{"key":"628_CR4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.bbrc.2013.06.114","volume":"437","author":"HJ Ahn","year":"2013","unstructured":"Ahn, H.J., G. Kim, and K.S. Park. 2013. Ell3 stimulates proliferation, drug resistance, and cancer stem cell properties of breast cancer cells via a MEK\/ERK-dependent signaling pathway. Biochemical and Biophysical Research Communications 437: 557\u2013564.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"628_CR5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0099-5428(05)32002-8","volume":"32","author":"B Al-Hadiya","year":"2004","unstructured":"Al-Hadiya, B. 2004. Niclosamide: Comprehensive profile. Profiles of Drug Substances, Excipients and Related Methodology 32: 67\u201396.","journal-title":"Profiles of Drug Substances, Excipients and Related Methodology"},{"key":"628_CR6","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj, M., M.S. Wicha, A. Benito-Hernandez, S.J. Morrison, and M.F. Clarke. 2003. Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences USA 100: 3983\u20133988.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"628_CR7","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn, T.T., and K.B. Thor. 2004. Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery 3: 673\u2013683.","journal-title":"Nature Reviews Drug Discovery"},{"key":"628_CR8","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF00280130","volume":"42","author":"P Augustijns","year":"1992","unstructured":"Augustijns, P., P. Geusens, and N. Verbeke. 1992. Chloroquine levels in blood during chronic treatment of patients with rheumatoid arthritis. European Journal of Clinical Pharmacology 42: 429\u2013433.","journal-title":"European Journal of Clinical Pharmacology"},{"key":"628_CR9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1158\/1078-0432.CCR-12-1956","volume":"19","author":"M Axelson","year":"2013","unstructured":"Axelson, M., K. Liu, X. Jiang, K. He, J. Wang, H. Zhao, D. Kufrin, T. Palmby, Z. Dong, A.M. Russell, S. Miksinski, P. Keegan, and R. Pazdur. 2013. U.S. Food and Drug Administration approval: Vismodegib for recurrent, locally advanced, or metastatic basal cell carcinoma. Clinical Cancer Research 19: 2289\u20132293.","journal-title":"Clinical Cancer Research"},{"key":"628_CR10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pdi.606","volume":"21","author":"CJ Bailey","year":"2004","unstructured":"Bailey, C.J., and C. Day. 2004. Metformin: Its botanical background. Practical Diabetes International 21: 115\u2013117.","journal-title":"Practical Diabetes International"},{"key":"628_CR11","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","volume":"334","author":"CJ Bailey","year":"1996","unstructured":"Bailey, C.J., and R.C. Turner. 1996. Metformin. New England Journal of Medicine 334: 574\u2013579.","journal-title":"New England Journal of Medicine"},{"key":"628_CR12","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1158\/1535-7163.MCT-13-0948","volume":"13","author":"A Balic","year":"2014","unstructured":"Balic, A., M.D. Sorensen, S.M. Trabulo, B. Sainz Jr, M. Cioffi, C.R. Vieira, I. Miranda-Lorenzo, M. Hidalgo, J. Kleeff, M. Erkan, and C. Heeschen. 2014. Chloroquine targets pancreatic cancer stem cells via inhibition of CXCR4 and hedgehog signaling. Molecular Cancer Therapeutics 13: 1758\u20131771.","journal-title":"Molecular Cancer Therapeutics"},{"key":"628_CR13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/1940-6207.CAPR-11-0299","volume":"5","author":"B Bao","year":"2012","unstructured":"Bao, B., Z. Wang, S. Ali, A. Ahmad, A.S. Azmi, S.H. Sarkar, S. Banerjee, D. Kong, Y. Li, S. Thakur, and F.H. Sarkar. 2012. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prevention Research 5: 355\u2013364.","journal-title":"Cancer Prevention Research"},{"key":"628_CR14","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1242\/jcs.123810","volume":"126","author":"WY Cai","year":"2013","unstructured":"Cai, W.Y., T.Z. Wei, Q.C. Luo, Q.W. Wu, Q.F. Liu, M. Yang, G.D. Ye, J.F. Wu, Y.Y. Chen, and G.B. Sun. 2013. The Wnt\u2013\u03b2-catenin pathway represses let-7 microRNA expression through transactivation of Lin28 to augment breast cancer stem cell expansion. Journal of Cell Science 126: 2877\u20132889.","journal-title":"Journal of Cell Science"},{"key":"628_CR15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/aps.2013.27","volume":"34","author":"K Chen","year":"2013","unstructured":"Chen, K., Y.H. Huang, and J.L. Chen. 2013. Understanding and targeting cancer stem cells: Therapeutic implications and challenges. Acta Pharmacologica Sinica 34: 732\u2013740.","journal-title":"Acta Pharmacologica Sinica"},{"key":"628_CR16","doi-asserted-by":"crossref","first-page":"10267","DOI":"10.1021\/bi9009677","volume":"48","author":"M Chen","year":"2009","unstructured":"Chen, M., J. Wang, J. Lu, M.C. Bond, X.R. Ren, H.K. Lyerly, L.S. Barak, and W. Chen. 2009. The anti-helminthic niclosamide inhibits Wnt\/Frizzled1 signaling. Biochemistry 48: 10267\u201310274.","journal-title":"Biochemistry"},{"key":"628_CR17","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/stem.1746","volume":"32","author":"DS Choi","year":"2014","unstructured":"Choi, D.S., E. Blanco, Y.S. Kim, A.A. Rodriguez, H. Zhao, T.H. Huang, C.L. Chen, G.X. Jin, M.D. Landis, L.A. Burey, W. Qian, S.M. Granados, B. Dave, H.H. Wong, M. Ferrari, S.T. Wong, and J.C. Chang. 2014. Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1. Stem Cells 32: 2309\u20132323.","journal-title":"Stem Cells"},{"key":"628_CR18","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nchembio806","volume":"2","author":"CR Chong","year":"2006","unstructured":"Chong, C.R., X. Chen, L. Shi, J.O. Liu, and D.J. Sullivan Jr. 2006. A clinical drug library screen identifies astemizole as an antimalarial agent. Nature Chemical Biology 2: 415\u2013416.","journal-title":"Nature Chemical Biology"},{"key":"628_CR19","doi-asserted-by":"crossref","first-page":"10946","DOI":"10.1158\/0008-5472.CAN-05-2018","volume":"65","author":"AT Collins","year":"2005","unstructured":"Collins, A.T., P.A. Berry, C. Hyde, M.J. Stower, and N.J. Maitland. 2005. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Research 65: 10946\u201310951.","journal-title":"Cancer Research"},{"key":"628_CR81","doi-asserted-by":"crossref","unstructured":"Curley, M.D., V.A. Therrien, C.L. Cummings, P.A. Sergent, C.R. Koulouris, A.M. Friel, D.J. Roberts, M.V. Seiden, D.T. Scadden, B.R. Rueda, and R. Foster. 2009. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer. Stem Cells. 27: 2875\u20132883.","DOI":"10.1002\/stem.236"},{"key":"628_CR20","first-page":"e01534","volume":"5","author":"DM Czyz","year":"2014","unstructured":"Czyz, D.M., L.P. Potluri, N. Jain-Gupta, S.P. Riley, J.J. Martinez, T.L. Steck, S. Crosson, H.A. Shuman, and J.E. Gabay. 2014. Host-directed antimicrobial drugs with broad-spectrum efficacy against intracellular bacterial pathogens. mBio 5: e01534; 14.","journal-title":"mBio."},{"key":"628_CR82","doi-asserted-by":"crossref","unstructured":"Dalerba P, S.J. Dylla, I.K. Park, R. Liu, X.H. Wang, R.W. Cho, T. Hoey, A. Gurney, E.H. Huang, D.M. Simeone, A.A Shelton, G. Parmiani, C. Castelli, and M.F. Clarke. 2007. Phenotypic characterization of human colorectal cancer stem cells. Proceedings of the National Academy of Sciences USA 104: 10158\u201310163.","DOI":"10.1073\/pnas.0703478104"},{"key":"628_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10911-009-9109-9","volume":"14","author":"M Dean","year":"2009","unstructured":"Dean, M. 2009. ABC transporters, drug resistance, and cancer stem cells. Journal of Mammary Gland Biology Neoplasia 14: 3\u20139.","journal-title":"Journal of Mammary Gland Biology Neoplasia."},{"key":"628_CR83","doi-asserted-by":"crossref","unstructured":"DeCastro, A.J., P. Cherukuri, A. Balboni, J. DiRenzo. 2015. \u0394NP63\u03b1 transcriptionally activates chemokine receptor 4 (CXCR4) expression to regulate breast cancer stem cell activity and chemotaxis. Molecular Cancer Therapeutics 14: 225\u2013235.","DOI":"10.1158\/1535-7163.MCT-14-0194"},{"key":"628_CR22","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/nchembio873","volume":"3","author":"P Diamandis","year":"2007","unstructured":"Diamandis, P., J. Wildenhain, I.D. Clarke, A.G. Sacher, J. Graham, D.S. Bellows, E.K. Ling, R.J. Ward, L.G. Jamieson, M. Tyers, and P.B. Dirks. 2007. Chemical genetics reveals a complex functional ground state of neural stem cells. Nature Chemical Biology 3: 268\u2013273.","journal-title":"Nature Chemical Biology"},{"key":"628_CR23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1158\/1541-7786.MCR-07-2159","volume":"6","author":"N Doudican","year":"2008","unstructured":"Doudican, N., A. Rodriguez, I. Osman, and S.J. Orlow. 2008. Mebendazole induces apoptosis via Bcl-2 inactivation in chemoresistant melanoma cells. Molecular Cancer Research 6: 1308\u20131315.","journal-title":"Molecular Cancer Research"},{"key":"628_CR84","doi-asserted-by":"crossref","unstructured":"Eramo, A., F. Lotti, G. Sette, E. Pilozzi, M. Biffoni, A. Di Virgilio, C. Conticello, L. Ruco, C. Peschle, and R.De Maria. 2008. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death & Differentiation 15: 504\u2013514.","DOI":"10.1038\/sj.cdd.4402283"},{"key":"628_CR85","doi-asserted-by":"crossref","unstructured":"Fang, D., T.K. Nguyen, K. Leishear, R. Finko, A.N. Kulp, S. Hotz, P.A. Van Belle, X.W. Xu, D.E. Elder, M. Herlyn. 2005. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Research 65: 9328\u20139337.","DOI":"10.1158\/0008-5472.CAN-05-1343"},{"key":"628_CR24","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.2174\/15680266113136660166","volume":"13","author":"J Finsterer","year":"2013","unstructured":"Finsterer, J., and M. Frank. 2013. Repurposed drugs in metabolic disorders. Current Topics in Medicinal Chemistry 13: 2386\u20132394.","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"628_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0306-3623(96)00149-8","volume":"28","author":"GJ Frayha","year":"1997","unstructured":"Frayha, G.J., J.D. Smyth, J.G. Gobert, and J. Savel. 1997. The mechanisms of action of antiprotozoal and anthelmintic drugs in man. General Pharmacology 28: 273\u2013299.","journal-title":"General Pharmacology"},{"key":"628_CR86","doi-asserted-by":"crossref","unstructured":"Gibbs, C.P., V.G. Kukekov, J.D. Reith, O. Tchigrinova, O.N. Suslov, E.W. Scott, S.C. Ghivizzani, T.N Ignatova, and D.A. Steindler. 2005. Stem-like cells in bone sarcomas: Implications for tumorigenesis. Neoplasia. 7: 967\u2013976.","DOI":"10.1593\/neo.05394"},{"key":"628_CR26","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2009.06.034","volume":"138","author":"PB Gupta","year":"2009","unstructured":"Gupta, P.B., T.T. Onder, G. Jiang, K. Tao, C. Kuperwasser, R.A. Weinberg, and E.S. Lander. 2009. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138: 645\u2013659.","journal-title":"Cell"},{"key":"628_CR27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00436-006-0313-x","volume":"100","author":"E Hempelmann","year":"2007","unstructured":"Hempelmann, E. 2007. Hemozoin biocrystallization in Plasmodium falciparum and the antimalarial activity of crystallization inhibitors. Parasitology Research 100: 671\u2013676.","journal-title":"Parasitology Research"},{"key":"628_CR87","doi-asserted-by":"crossref","unstructured":"Hermann, P.C., S.L. Huber, T. Herrler, A. Aicher, J.W. Ellwart, M. Guba, C.J. Bruns, and C. Heeschen. 2007. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 1: 313\u2013323.","DOI":"10.1016\/j.stem.2007.06.002"},{"key":"628_CR28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.18632\/oncotarget.707","volume":"3","author":"P Hothi","year":"2012","unstructured":"Hothi, P., T.J. Martins, L.P. Chen, L. Deleyrolle, J.G. Yoon, B. Reynolds, and G. Foltz. 2012. High-throughput chemical screens identify disulfiram as an inhibitor of human glioblastoma stem cells. Oncotarget 3: 1124\u20131136.","journal-title":"Oncotarget."},{"key":"628_CR88","doi-asserted-by":"crossref","unstructured":"Huang, E.H., M.J. Hynes, T. Zhang, C. Ginestier, G. Dontu, H. Appelman, J.Z. Fields, M.S. Wicha, and B.M. Boman. 2009. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Research 69: 3382\u20133389.","DOI":"10.1158\/0008-5472.CAN-08-4418"},{"key":"628_CR29","doi-asserted-by":"crossref","first-page":"80ps16","DOI":"10.1126\/scitranslmed.3001862","volume":"3","author":"R Huang","year":"2011","unstructured":"Huang, R., N. Southall, Y. Wang, A. Yasgar, P. Shinn, A. Jadhav, D.T. Nguyen, and C.P. Austin. 2011. The NCGC pharmaceutical collection: A comprehensive resource of clinically approved drugs enabling repurposing and chemical genomics. Science Translational Medicine 3: 80ps16.","journal-title":"Science Translational Medicine"},{"key":"628_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.toxlet.2014.03.020","volume":"227","author":"R Jiang","year":"2014","unstructured":"Jiang, R., Y. Li, A. Zhang, B. Wang, Y. Xu, W. Xu, Y. Zhao, F. Luo, and Q. Liu. 2014. The acquisition of cancer stem cell-like properties and neoplastic transformation of human keratinocytes induced by arsenite involves epigenetic silencing of let-7c via Ras\/NF-\u03baB. Toxicology Letters 227: 91\u201398.","journal-title":"Toxicology Letters"},{"key":"628_CR31","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/hmg\/ddt542","volume":"23","author":"A Ketley","year":"2014","unstructured":"Ketley, A., C.Z. Chen, X. Li, S. Arya, T.E. Robinson, J. Granados-Riveron, I. Udosen, G.E. Morris, I. Holt, D. Furling, S. Chaouch, B. Haworth, N. Southall, P. Shinn, W. Zheng, C.P. Austin, C.J. Hayes, and J.D. Brook. 2014. High-content screening identifies small molecules that remove nuclear foci, affect MBNL distribution and CELF1 protein levels via a PKC-independent pathway in myotonic dystrophy cell lines. Human Molecular Genetics 23: 1551\u20131562.","journal-title":"Human Molecular Genetics"},{"key":"628_CR32","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1038\/bcj.2011.38","volume":"1","author":"FL Khanim","year":"2011","unstructured":"Khanim, F.L., B.A. Merrick, H.V. Giles, M. Jankute, J.B. Jackson, L.J. Giles, J. Birtwistle, C.M. Bunce, and M.T. Drayson. 2011. Redeployment-based drug screening identifies the anti-helminthic niclosamide as anti-myeloma therapy that also reduces free light chain production. Blood Cancer Journal 1: e39.","journal-title":"Blood Cancer Journal."},{"key":"628_CR89","doi-asserted-by":"crossref","unstructured":"Kim, C.F., E.L. Jackson, A.E. Woolfenden, S. Lawrence, I. Babar, S. Vogel, D. Crowley, R.T. Bronson, and T. Jacks. 2005. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823\u2013835.","DOI":"10.1016\/j.cell.2005.03.032"},{"key":"628_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/mc.21844","volume":"52","author":"LC Kimlin","year":"2013","unstructured":"Kimlin, L.C., G. Casagrande, and V.M. Virador. 2013. In vitro three-dimensional (3D) models in cancer research: An update. Molecular Carcinogenesis 52: 167\u2013182.","journal-title":"Molecular Carcinogenesis"},{"key":"628_CR34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","volume":"73","author":"T Kimura","year":"2013","unstructured":"Kimura, T., Y. Takabatake, A. Takahashi, and Y. Isaka. 2013. Chloroquine in cancer therapy: A double-edged sword of autophagy. Cancer Research 73: 3\u20137.","journal-title":"Cancer Research"},{"key":"628_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00436-012-2886-x","volume":"111","author":"K Krafts","year":"2012","unstructured":"Krafts, K., E. Hempelmann, and A. Skorska-Stania. 2012. From methylene blue to chloroquine: A brief review of the development of an antimalarial therapy. Parasitology Research 111: 1\u20136.","journal-title":"Parasitology Research"},{"key":"628_CR36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","volume":"367","author":"T Lapidot","year":"1994","unstructured":"Lapidot, T., C. Sirard, J. Vormoor, B. Murdoch, T. Hoang, J. Caceres-Cortes, M. Minden, B. Paterson, M.A. Caligiuri, and J.E. Dick. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367: 645\u2013648.","journal-title":"Nature"},{"key":"628_CR37","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","volume":"67","author":"C Li","year":"2007","unstructured":"Li, C., D.G. Heidt, P. Dalerba, C.F. Burant, L. Zhang, V. Adsay, M. Wicha, M.F. Clarke, and D.M. Simeone. 2007. Identification of pancreatic cancer stem cells. Cancer Research 67: 1030\u20131037.","journal-title":"Cancer Research"},{"key":"628_CR38","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1158\/1535-7163.MCT-13-0095","volume":"12","author":"R Li","year":"2013","unstructured":"Li, R., Z.L. Hu, S.Y. Sun, Z.G. Chen, T.K. Owonikoko, G.L. Sica, S.S. Ramalingam, W.J. Curran, F.R. Khuri, and X.M. Deng. 2013. Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer. Molecular Cancer Therapeutics 12: 2200\u20132212.","journal-title":"Molecular Cancer Therapeutics"},{"key":"628_CR39","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2014.04.003","volume":"349","author":"Y Li","year":"2014","unstructured":"Li, Y., P.K. Li, M.J. Roberts, R.C. Arend, R.S. Samant, and D.J. Buchsbaum. 2014. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Letters 349: 8\u201314.","journal-title":"Cancer Letters"},{"key":"628_CR40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cdd.2013.131","volume":"21","author":"PP Liu","year":"2014","unstructured":"Liu, P.P., J. Liao, Z.J. Tang, W.J. Wu, J. Yang, Z.L. Zeng, Y. Hu, P. Wang, H.Q. Ju, R.H. Xu, and P. Huang. 2014. Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway. Cell Death and Differentiation 21: 124\u2013135.","journal-title":"Cell Death and Differentiation"},{"key":"628_CR41","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1158\/0008-5472.CAN-06-0054","volume":"66","author":"S Liu","year":"2006","unstructured":"Liu, S., G. Dontu, I.D. Mantle, S. Patel, N.S. Ahn, K.W. Jackson, P. Suri, and M.S. Wicha. 2006. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research 66: 6063\u20136071.","journal-title":"Cancer Research"},{"key":"628_CR42","doi-asserted-by":"crossref","first-page":"e76518","DOI":"10.1371\/journal.pone.0076518","volume":"8","author":"E Lonardo","year":"2013","unstructured":"Lonardo, E., M. Cioffi, P. Sancho, Y. Sanchez-Ripoll, S.M. Trabulo, J. Dorado, A. Balic, M. Hidalgo, and C. Heeschen. 2013. Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells. PLoS One 8: e76518.","journal-title":"PLoS One"},{"key":"628_CR43","doi-asserted-by":"crossref","first-page":"e29290","DOI":"10.1371\/journal.pone.0029290","volume":"6","author":"W Lu","year":"2011","unstructured":"Lu, W., C. Lin, M.J. Roberts, W.R. Waud, G.A. Piazza, and Y. Li. 2011. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt\/beta-catenin pathway. PLoS One 6: e29290.","journal-title":"PLoS One"},{"key":"628_CR44","first-page":"24","volume":"128","author":"OJ Lucis","year":"1983","unstructured":"Lucis, O.J. 1983. The status of metformin in Canada. Canadian Medical Association Journal 128: 24\u201326.","journal-title":"Canadian Medical Association Journal"},{"key":"628_CR45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12015-010-9208-4","volume":"7","author":"I Ma","year":"2011","unstructured":"Ma, I., and A.L. Allan. 2011. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Reviews and Reports 7: 292\u2013306.","journal-title":"Stem Cell Reviews and Reports"},{"key":"628_CR46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","volume":"510","author":"AK Madiraju","year":"2014","unstructured":"Madiraju, A.K., D.M. Erion, Y. Rahimi, X.M. Zhang, D.T. Braddock, R.A. Albright, B.J. Prigaro, J.L. Wood, S. Bhanot, M.J. MacDonald, M.J. Jurczak, J.P. Camporez, H.Y. Lee, G.W. Cline, V.T. Samuel, R.G. Kibbey, and G.I. Shulman. 2014. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510: 542\u2013546.","journal-title":"Nature"},{"key":"628_CR47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","volume":"133","author":"SA Mani","year":"2008","unstructured":"Mani, S.A., W. Guo, M.J. Liao, E.N. Eaton, A. Ayyanan, A.Y. Zhou, M. Brooks, F. Reinhard, C.C. Zhang, M. Shipitsin, L.L. Campbell, K. Polyak, C. Brisken, J. Yang, and R.A. Weinberg. 2008. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704\u2013715.","journal-title":"Cell"},{"key":"628_CR48","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1038\/nm.3618","volume":"20","author":"F Mei","year":"2014","unstructured":"Mei, F., S.P. Fancy, Y.A. Shen, J. Niu, C. Zhao, B. Presley, E. Miao, S. Lee, S.R. Mayoral, S.A. Redmond, A. Etxeberria, L. Xiao, R.J. Franklin, A. Green, S.L. Hauser, and J.R. Chan. 2014. Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nature Medicine 20: 954\u2013960.","journal-title":"Nature Medicine"},{"key":"628_CR49","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/096120339600500313","volume":"5","author":"I Meinao","year":"1996","unstructured":"Meinao, I., E. Sato, L. Andrade, M. Ferraz, and E. Atra. 1996. Controlled trial with chloroquine diphosphate in systemic lupus erythematosus. Lupus 5: 237\u2013241.","journal-title":"Lupus."},{"key":"628_CR50","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nature03669","volume":"435","author":"F Michor","year":"2005","unstructured":"Michor, F., T.P. Hughes, Y. Iwasa, S. Branford, N.P. Shah, C.L. Sawyers, and M.A. Nowak. 2005. Dynamics of chronic myeloid leukaemia. Nature 435: 1267\u20131270.","journal-title":"Nature"},{"key":"628_CR51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jb\/mvr032","volume":"149","author":"T Mizushima","year":"2011","unstructured":"Mizushima, T. 2011. Drug discovery and development focusing on existing medicines: Drug re-profiling strategy. Journal of Biochemistry 149: 499\u2013505.","journal-title":"Journal of Biochemistry"},{"key":"628_CR52","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature05372","volume":"445","author":"CA O\u2019Brien","year":"2006","unstructured":"O\u2019Brien, C.A., A. Pollett, S. Gallinger, and J.E. Dick. 2006. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445: 106\u2013110.","journal-title":"Nature"},{"key":"628_CR53","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3892\/or.2014.3252","volume":"32","author":"G Oktem","year":"2014","unstructured":"Oktem, G., O. Sercan, U. Guven, R. Uslu, A. Uysal, G. Goksel, S. Ayla, and A. Bilir. 2014. Cancer stem cell differentiation: TGF\u03b21 and versican may trigger molecules for the organization of tumor spheroids. Oncology Reports 32: 641\u2013649.","journal-title":"Oncology Reports"},{"key":"628_CR54","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1158\/0008-5472.CAN-10-3978","volume":"71","author":"T Osada","year":"2011","unstructured":"Osada, T., M. Chen, X.Y. Yang, I. Spasojevic, J.B. Vandeusen, D. Hsu, B.M. Clary, T.M. Clay, W. Chen, M.A. Morse, and H.K. Lyerly. 2011. Antihelminth compound niclosamide downregulates Wnt signaling and elicits antitumor responses in tumors with activating APC mutations. Cancer Research 71: 4172\u20134182.","journal-title":"Cancer Research"},{"key":"628_CR55","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1042\/bj3480607","volume":"348","author":"MR Owen","year":"2000","unstructured":"Owen, M.R., E. Doran, and A.P. Halestrap. 2000. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal 348: 607\u2013614.","journal-title":"Biochemical Journal"},{"key":"628_CR56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.7326\/0003-4819-102-4-550","volume":"102","author":"RD Pearson","year":"1985","unstructured":"Pearson, R.D., and E.L. Hewlett. 1985. Niclosamide therapy for tapeworm infections. Annals of Internal Medicine 102: 550\u2013551.","journal-title":"Annals of Internal Medicine"},{"key":"628_CR90","doi-asserted-by":"crossref","unstructured":"Prince, M., R. Sivanandan, A. Kaczorowski, G. Wolf, M. Kaplan, P. Dalerba, I. Weissman, M. Clarke, L. Ailles. 2007. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences USA 104: 973\u2013978.","DOI":"10.1073\/pnas.0610117104"},{"key":"628_CR57","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1021\/ml100146z","volume":"1","author":"XM Ren","year":"2010","unstructured":"Ren, X.M., L. Duan, Q.A. He, Z. Zhang, Y. Zhou, D.H. Wu, J.X. Pan, D.Q. Pei, and K. Ding. 2010. Identification of niclosamide as a new small-molecule inhibitor of the STAT3 signaling pathway. ACS Medicinal Chemistry Letters 1: 454\u2013459.","journal-title":"ACS Medicinal Chemistry Letters"},{"key":"628_CR58","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature05384","volume":"445","author":"L Ricci-Vitiani","year":"2006","unstructured":"Ricci-Vitiani, L., D.G. Lombardi, E. Pilozzi, M. Biffoni, M. Todaro, C. Peschle, and R. De Maria. 2006. Identification and expansion of human colon-cancer-initiating cells. Nature 445: 111\u2013115.","journal-title":"Nature"},{"key":"628_CR59","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.4161\/cc.26063","volume":"12","author":"TJ Robinson","year":"2013","unstructured":"Robinson, T.J., M. Pai, J.C. Liu, F. Vizeacoumar, T. Sun, S.E. Egan, A. Datti, J. Huang, and E. Zacksenhaus. 2013. High-throughput screen identifies disulfiram as a potential therapeutic for triple-negative breast cancer cells Interaction with IQ motif-containing factors. Cell Cycle 12: 3013\u20133024.","journal-title":"Cell Cycle"},{"key":"628_CR60","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1126\/science.1171837","volume":"324","author":"JM Rosen","year":"2009","unstructured":"Rosen, J.M., and C.T. Jordan. 2009. The increasing complexity of the cancer stem cell paradigm. Science 324: 1670\u20131673.","journal-title":"Science"},{"key":"628_CR91","doi-asserted-by":"crossref","unstructured":"Sabet, M.N., A. Rakhshan, E. Erfani, and Z. Madjd. 2010. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors. Asian Pacific Journal of Cancer Prevention 15: 8161\u20138169.","DOI":"10.7314\/APJCP.2014.15.19.8161"},{"key":"628_CR92","doi-asserted-by":"crossref","unstructured":"Schatton, T., G.F. Murphy, N.Y. Frank, K. Yamaura, A.M. Waaga-Gasser, M. Gasser, Q. Zhan, S. Jordan, L.M. Duncan, C. Weishaupt, R.C. Fuhlbrigge, T.S. Kupper, M.H. Sayegh, and M.H. Frankz. 2008. Identification of cells initiating human melanomas. Nature 451: 345\u2013349.","DOI":"10.1038\/nature06489"},{"key":"628_CR61","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1126\/science.1120781","volume":"310","author":"RJ Shaw","year":"2005","unstructured":"Shaw, R.J., K.A. Lamia, D. Vasquez, S.H. Koo, N. Bardeesy, R.A. Depinho, M. Montminy, and L.C. Cantley. 2005. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310: 1642\u20131646.","journal-title":"Science"},{"key":"628_CR62","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/jnci\/djq457","volume":"102","author":"JS Shim","year":"2010","unstructured":"Shim, J.S., Y. Matsui, S. Bhat, B.A. Nacev, J. Xu, H.E. Bhang, S. Dhara, K.C. Han, C.R. Chong, M.G. Pomper, A. So, and J.O. Liu. 2010. Effect of nitroxoline on angiogenesis and growth of human bladder cancer. Journal of the National Cancer Institute 102: 1855\u20131873.","journal-title":"Journal of the National Cancer Institute"},{"key":"628_CR63","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1093\/jnci\/djs396","volume":"104","author":"JS Shim","year":"2012","unstructured":"Shim, J.S., R. Rao, K. Beebe, L. Neckers, I. Han, R. Nahta, and J.O. Liu. 2012. Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir. Journal of the National Cancer Institute 104: 1576\u20131590.","journal-title":"Journal of the National Cancer Institute"},{"key":"628_CR64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1017\/S0009840X13002084","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., J.M. Ma, Z.H. Zou, and A. Jemal. 2014. Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 64: 9\u201329.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"628_CR65","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh, S.K., C. Hawkins, I.D. Clarke, J.A. Squire, J. Bayani, T. Hide, R.M. Henkelman, M.D. Cusimano, and P.B. Dirks. 2004. Identification of human brain tumour initiating cells. Nature 432: 396\u2013401.","journal-title":"Nature"},{"key":"628_CR66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejphar.2009.06.063","volume":"625","author":"VR Solomon","year":"2009","unstructured":"Solomon, V.R., and H. Lee. 2009. Chloroquine and its analogs: A new promise of an old drug for effective and safe cancer therapies. European Journal of Pharmacology 625: 220\u2013233.","journal-title":"European Journal of Pharmacology"},{"key":"628_CR67","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.2898810","volume":"241","author":"GJ Spangrude","year":"1988","unstructured":"Spangrude, G.J., S. Heimfeld, and I.L. Weissman. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241: 58\u201362.","journal-title":"Science"},{"key":"628_CR68","first-page":"U799","volume":"117","author":"P Story","year":"2004","unstructured":"Story, P., and A. Doube. 2004. A case of human poisoning by salinomycin, an agricultural antibiotic. New Zealand Medical Journal 117: U799.","journal-title":"New Zealand Medical Journal"},{"key":"628_CR69","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter, S.M. 2014. Overcoming drug development bottlenecks with repurposing: Old drugs learn new tricks. Nature Medicine 20: 590\u2013591.","journal-title":"Nature Medicine"},{"key":"628_CR70","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/978-1-61779-815-3_32","volume":"879","author":"V Tirino","year":"2012","unstructured":"Tirino, V., V. Desiderio, F. Paino, G. Papaccio, and M. De Rosa. 2012. Methods for cancer stem cell detection and isolation. Methods in Molecular Biology 879: 513\u2013529.","journal-title":"Methods in Molecular Biology"},{"key":"628_CR101","doi-asserted-by":"crossref","unstructured":"Tseng, C.N., Y.R. Hong, H.W. Chang, T.J. Yu, T.W. Hung, M.F. Hou, S.S. Yuan, C.L. Cho, C.T. Liu, C.C. Chiu, and C.J. Huang. 2014. Brefeldin A reduces anchorage-independent survival, cancer stem cell potential and migration of MDA-MB-231 human breast cancer cells. Molecules 19: 17464\u201317477.","DOI":"10.3390\/molecules191117464"},{"key":"628_CR71","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2217\/nnm.12.22","volume":"7","author":"S Vinogradov","year":"2012","unstructured":"Vinogradov, S., and X. Wei. 2012. Cancer stem cells and drug resistance: The potential of nanomedicine. Nanomedicine (London) 7: 597\u2013615.","journal-title":"Nanomedicine (London)."},{"key":"628_CR72","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/nrc2499","volume":"8","author":"JE Visvader","year":"2008","unstructured":"Visvader, J.E., and G.J. Lindeman. 2008. Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nature Reviews Cancer 8: 755\u2013768.","journal-title":"Nature Reviews Cancer"},{"key":"628_CR73","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/jcb.22065","volume":"106","author":"AM Wang","year":"2009","unstructured":"Wang, A.M., H.H. Ku, Y.C. Liang, Y.C. Chen, Y.M. Hwu, and T.S. Yeh. 2009. The autonomous Notch signal pathway is activated by baicalin and baicalein but is suppressed by niclosamide in k562 cells. Journal of Cellular Biochemistry 106: 682\u2013692.","journal-title":"Journal of Cellular Biochemistry"},{"key":"628_CR74","doi-asserted-by":"crossref","first-page":"e74538","DOI":"10.1371\/journal.pone.0074538","volume":"8","author":"YC Wang","year":"2013","unstructured":"Wang, Y.C., T.K. Chao, C.C. Chang, Y.T. Yo, M.H. Yu, and H.C. Lai. 2013. Drug screening identifies niclosamide as an inhibitor of breast cancer stem-like cells. PLoS One 8: e74538.","journal-title":"PLoS One"},{"key":"628_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neo.2014.12.004","volume":"17","author":"LB Weiswald","year":"2015","unstructured":"Weiswald, L.B., D. Bellet, and V. Dangles-Marie. 2015. Spherical cancer models in tumor biology. Neoplasia 17: 1\u201315.","journal-title":"Neoplasia."},{"key":"628_CR76","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1158\/1078-0432.CCR-12-2895","volume":"19","author":"A Wieland","year":"2013","unstructured":"Wieland, A., D. Trageser, S. Gogolok, R. Reinartz, H. Hofer, M. Keller, A. Leinhaas, R. Schelle, S. Normann, L. Klaas, A. Waha, P. Koch, R. Fimmers, T. Pietsch, A.T. Yachnis, D.W. Pincus, D.A. Steindler, O. Brustle, M. Simon, M. Glas, and B. Scheffler. 2013. Anticancer effects of niclosamide in human glioblastoma. Clinical Cancer Research 19: 4124\u20134136.","journal-title":"Clinical Cancer Research"},{"key":"628_CR77","doi-asserted-by":"crossref","first-page":"4764","DOI":"10.1073\/pnas.0910872107","volume":"107","author":"J Xu","year":"2010","unstructured":"Xu, J., Y. Dang, Y.R. Ren, and J.O. Liu. 2010. Cholesterol trafficking is required for mTOR activation in endothelial cells. Proceedings of the National Academy of Sciences USA 107: 4764\u20134769.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"628_CR93","doi-asserted-by":"crossref","unstructured":"Yang, C.H., H.L. Wang, Y.S. Lin, K.P. Kumar, H.C. Lin, C.J. Chang, C.C. Lu, T.T. Huang, J. Martel, D.M. Ojcius, Y.S. Chang, J.D. Young, and H.C. Lai. 2014. Identification of CD24 as a cancer stem cell marker in human nasopharyngeal carcinoma. PLoS ONE 9: e99412.","DOI":"10.1371\/journal.pone.0099412"},{"key":"628_CR94","doi-asserted-by":"crossref","unstructured":"Yang, Z.F., D.W. Ho, M.N. Ng, C.K. Lau, W.C. Yu, P. Ngai, P.W. Chu, C.T. Lam, R.T. Poon, and S.T. Fan. 2008. Significance of CD90(+) cancer stem cells in human liver cancer. Cancer Cell 13: 153\u2013166.","DOI":"10.1016\/j.ccr.2008.01.013"},{"key":"628_CR95","unstructured":"Yin, B., Y. Zeng, G. Liu, X.T. Wang, P. Wang, and Y.S. Song. 2014. MAGE-A3 is highly expressed in a cancer stem cell-like side population of bladder cancer cells. International Journal of Clinical and Experimental Pathology 7: 2934\u20132941."},{"key":"628_CR78","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1158\/1535-7163.MCT-12-0002","volume":"11","author":"YT Yo","year":"2012","unstructured":"Yo, Y.T., Y.W. Lin, Y.C. Wang, C. Balch, R.L. Huang, M.W. Chan, H.K. Sytwu, C.K. Chen, C.C. Chang, and K.P. Nephew. 2012. Growth inhibition of ovarian tumor\u2013initiating cells by niclosamide. Molecular Cancer Therapeutics 11: 1703\u20131712.","journal-title":"Molecular Cancer Therapeutics"},{"key":"628_CR79","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1158\/1535-7163.MCT-13-0608","volume":"13","author":"S You","year":"2014","unstructured":"You, S., R. Li, D. Park, M. Xie, G.L. Sica, Y. Cao, Z.Q. Xiao, and X. Deng. 2014. Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer. Molecular Cancer Therapeutics 13: 606\u2013616.","journal-title":"Molecular Cancer Therapeutics"},{"key":"628_CR80","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G Zhou","year":"2001","unstructured":"Zhou, G., R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. Journal of Clinical Investigation 108: 1167\u20131174.","journal-title":"Journal of Clinical Investigation"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0628-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-015-0628-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-015-0628-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T23:16:09Z","timestamp":1691795769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-015-0628-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":96,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1007\/s12272-015-0628-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}